ATE119157T1 - Pyrimidinderivate zur erhöhung der antitumoraktivität. - Google Patents

Pyrimidinderivate zur erhöhung der antitumoraktivität.

Info

Publication number
ATE119157T1
ATE119157T1 AT92911036T AT92911036T ATE119157T1 AT E119157 T1 ATE119157 T1 AT E119157T1 AT 92911036 T AT92911036 T AT 92911036T AT 92911036 T AT92911036 T AT 92911036T AT E119157 T1 ATE119157 T1 AT E119157T1
Authority
AT
Austria
Prior art keywords
antitumor activity
pyrimidine derivatives
increase antitumor
increase
derivatives
Prior art date
Application number
AT92911036T
Other languages
English (en)
Inventor
Jotham Wadsworth Coe
Anton Franz Josef Fliri
Takushi Kaneko
Eric Robert Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE119157T1 publication Critical patent/ATE119157T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Indole Compounds (AREA)
AT92911036T 1991-04-17 1992-03-30 Pyrimidinderivate zur erhöhung der antitumoraktivität. ATE119157T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68689991A 1991-04-17 1991-04-17

Publications (1)

Publication Number Publication Date
ATE119157T1 true ATE119157T1 (de) 1995-03-15

Family

ID=24758194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911036T ATE119157T1 (de) 1991-04-17 1992-03-30 Pyrimidinderivate zur erhöhung der antitumoraktivität.

Country Status (22)

Country Link
EP (1) EP0580753B1 (de)
JP (1) JPH0819121B2 (de)
CN (1) CN1065863A (de)
AT (1) ATE119157T1 (de)
AU (1) AU653601B2 (de)
BR (1) BR9205906A (de)
CA (1) CA2108561A1 (de)
CZ (1) CZ390992A3 (de)
DE (2) DE69201559T2 (de)
DK (1) DK0580753T3 (de)
ES (1) ES2068714T3 (de)
FI (1) FI934565L (de)
GR (1) GR3015921T3 (de)
HU (1) HUT65177A (de)
IE (1) IE64915B1 (de)
MX (1) MX9201763A (de)
NO (1) NO933722D0 (de)
NZ (1) NZ242390A (de)
PT (1) PT100386A (de)
WO (1) WO1992018498A1 (de)
YU (1) YU39992A (de)
ZA (1) ZA922815B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188411B (de) * 1997-03-27 2002-09-21 Yuhan Corp
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
JP2003521468A (ja) 1999-03-17 2003-07-15 シグナル ファーマシューティカルズ， インコーポレイテッド エストロゲンレセプタを変調させるための化合物及び方法
US6593322B1 (en) 1999-03-17 2003-07-15 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US6630469B2 (en) 2000-05-09 2003-10-07 Bristol-Myers Squibb Company 5-HT7 receptor antagonists
JP5154728B2 (ja) 2000-07-24 2013-02-27 クレニツキー・ファーマシューティカルズ，インコーポレイテッド 神経栄養活性を有する置換５−アルキニルピリミジン
JP2005232081A (ja) * 2004-02-19 2005-09-02 Bayer Cropscience Ag ベンジルピリミジン誘導体の農園芸用殺菌剤としての利用
JP2010111702A (ja) 2009-02-16 2010-05-20 Tetsuya Nishio 複素環化合物、その製造法および用途
CN103333119A (zh) * 2013-05-28 2013-10-02 中国药科大学 1,2-二氢-6-甲基-4-取代氨基-5-嘧啶羧酸类化合物及其制备方法和用途
CN115232076A (zh) * 2022-07-25 2022-10-25 南通大学 苯氨基取代的嘧啶氨基酸衍生物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2744663B2 (ja) * 1988-12-29 1998-04-28 三井化学株式会社 ピリミジン類及びその薬学的に許容される塩類
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
FI934565A7 (fi) 1993-10-15
NZ242390A (en) 1994-09-27
PT100386A (pt) 1993-06-30
DE9290039U1 (de) 1993-12-09
FI934565A0 (fi) 1993-10-15
JPH0819121B2 (ja) 1996-02-28
IE64915B1 (en) 1995-09-20
HU9302929D0 (en) 1993-12-28
CZ390992A3 (en) 1994-03-16
ZA922815B (en) 1993-10-18
EP0580753A1 (de) 1994-02-02
EP0580753B1 (de) 1995-03-01
DE69201559D1 (de) 1995-04-06
GR3015921T3 (en) 1995-07-31
NO933722L (no) 1993-10-15
MX9201763A (es) 1992-10-01
AU653601B2 (en) 1994-10-06
AU1776192A (en) 1992-11-17
NO933722D0 (no) 1993-10-15
WO1992018498A1 (en) 1992-10-29
DE69201559T2 (de) 1995-07-13
DK0580753T3 (da) 1995-07-03
HUT65177A (en) 1994-05-02
ES2068714T3 (es) 1995-04-16
BR9205906A (pt) 1994-07-05
CA2108561A1 (en) 1992-10-18
YU39992A (sh) 1995-01-31
CN1065863A (zh) 1992-11-04
JPH06501023A (ja) 1994-01-27
FI934565L (fi) 1993-10-15
IE921214A1 (en) 1992-10-21

Similar Documents

Publication Publication Date Title
NO932954L (no) 2,4-diaminokinazolin-derivater for aa oppnaa oeket antitumoraktivitet
DK0556310T3 (da) Quinazolinderivater til forhøjelse af antitumoraktivitet
ATE79614T1 (de) Substituierte pyrimidine.
IL98110A0 (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic bases,their preparation and use
NO933722L (no) Pyrimidin-derivater for forbedring av antitumor-aktivitet
ES2195624T3 (es) Estimulacion electromagnetica de tejido cartilaginoso con empleo de fgf.
ATE237594T1 (de) Sulfonylpyrimidine derivate mit antitumor wirkung
FI880944A7 (fi) Yhdistelmäterapia, jossa käytetään antituumori-immunotoksiineja yhdessä tuumorin nekroositekijän kanssa.
DE3888541D1 (de) Verbesserung der toxizitätskurven in der chemotherapie.
DE3884347D1 (de) Pyrimidinderivate.
FI912963A0 (fi) Hjaernverksamheten oekande pyrimidinylderivat.
ATE59777T1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
ATE177643T1 (de) Eisentherapie mit saccharoseoctasulfateisenkomplex
IE863201L (en) Diamino pyrimidine derivatives.
RU93034452A (ru) Производные хиназолинов для усиления противоопухолевой активности, способ их получения, способ лечения и фармацевтическая композиция
ATE102826T1 (de) Verbesserung der toxizitaetskurven in der chemotherapie.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee